RAGNO, Pia
 Distribuzione geografica
Continente #
AS - Asia 9.429
NA - Nord America 5.351
EU - Europa 1.789
SA - Sud America 317
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 52
OC - Oceania 1
Totale 17.049
Nazione #
HK - Hong Kong 7.614
US - Stati Uniti d'America 5.264
SG - Singapore 847
IT - Italia 565
CN - Cina 476
UA - Ucraina 308
DE - Germania 247
BR - Brasile 238
RU - Federazione Russa 186
VN - Vietnam 165
FI - Finlandia 141
IE - Irlanda 99
TR - Turchia 81
FR - Francia 74
SE - Svezia 63
KR - Corea 51
CA - Canada 49
GB - Regno Unito 42
IN - India 42
AR - Argentina 30
BD - Bangladesh 30
IQ - Iraq 18
JP - Giappone 18
MX - Messico 18
ZA - Sudafrica 18
ES - Italia 13
SA - Arabia Saudita 13
CO - Colombia 12
PH - Filippine 12
EC - Ecuador 11
AE - Emirati Arabi Uniti 10
AT - Austria 10
PK - Pakistan 10
TN - Tunisia 8
ID - Indonesia 7
NL - Olanda 7
VE - Venezuela 7
CL - Cile 6
MY - Malesia 6
PL - Polonia 6
PY - Paraguay 6
UZ - Uzbekistan 6
EG - Egitto 5
JM - Giamaica 5
LT - Lituania 5
MA - Marocco 5
AL - Albania 4
DK - Danimarca 4
JO - Giordania 4
KE - Kenya 4
PE - Perù 4
CR - Costa Rica 3
DZ - Algeria 3
OM - Oman 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SC - Seychelles 1
TJ - Tagikistan 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 16.941
Città #
Hong Kong 7.608
Ann Arbor 1.158
Houston 502
Singapore 491
San Jose 422
Woodbridge 394
Jacksonville 376
Chandler 371
Princeton 270
Milan 230
Ashburn 225
Dallas 171
Wilmington 167
Munich 114
Dublin 98
Council Bluffs 94
Salerno 75
Beijing 73
Izmir 72
Andover 64
Lauterbourg 61
Nanjing 60
Boardman 58
Helsinki 54
The Dalles 51
New York 50
Rome 49
Ho Chi Minh City 46
Pellezzano 45
Los Angeles 42
Santa Clara 40
Shenyang 35
Moscow 31
Dong Ket 30
Hanoi 27
Jiaxing 26
São Paulo 24
Fairfield 22
Norwalk 21
Figino 20
Brooklyn 18
Hebei 17
Tokyo 17
Changsha 16
Chicago 16
Düsseldorf 16
Ottawa 16
Tianjin 16
Chennai 15
Montreal 15
Nanchang 15
London 14
Nuremberg 13
Orem 13
Turku 13
Columbus 12
Johannesburg 12
Shanghai 12
Redwood City 11
Seattle 11
Denver 10
Hillsboro 10
Jinan 10
Zhengzhou 10
Atlanta 9
Belo Horizonte 9
Boston 9
Falls Church 9
Frankfurt am Main 9
Jeddah 9
Mexico City 9
Nürnberg 9
Turin 9
Dearborn 8
Guangzhou 8
Haiphong 8
Manchester 8
Phoenix 8
Pune 8
San Diego 8
Brasília 7
Buffalo 7
Rio de Janeiro 7
San Francisco 7
Washington 7
Amsterdam 6
Montoro 6
Naples 6
Tashkent 6
Tunis 6
Charlotte 5
Da Nang 5
Eboli 5
Erbil 5
Jyväskylä 5
Lappeenranta 5
Memphis 5
Napoli 5
Oliveto Citra 5
Seoul 5
Totale 14.347
Nome #
A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs. 1.083
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 914
Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells 908
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors 867
Urokinase-type plasminogen-activator receptor in human thyroid cells. 618
PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer 574
Role of uPA/uPAR in the Modulation of Angiogenesis 536
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism. 524
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 480
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 381
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 320
Discovery of new small molecules targeting the vitronectin binding site of the urokinase receptor that block cancer cell invasion. 309
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells 285
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 281
Expression and function of the UPA dependent plasminogen activation system in scleroderma 278
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor 268
RhoB regulates uPAR signalling 258
Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma. 232
The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface 232
The urokinase-receptor in infectious diseases. 218
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 214
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 210
67 kDa laminin receptor: structure, function and role in cancer and infection. 184
The urokinase receptor takes control of cell migration through a mechanism involving integrins and fMLF receptors. 182
Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells 174
Role of the urokinase receptor in hematopoietic stem cell transplantation 173
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. 172
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 166
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 164
Involvement of the urokinase receptor in the cross-talk between hematopoietic stem/progenitor cells and the bone marrow microenvironment. 163
Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. 161
Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR. 160
Discovery of new small molecules targeting the vitronectin binding site of the urokinase receptor that block normal and leukemic cell migration 154
A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation. 153
Expression and function of the uPA-uPAR system and the FMLP receptor family in human basophils 153
Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells. 152
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 152
PED/PEA-15 interacts with the 67 kDa laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis. 150
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor 146
miRNA-MEDIATED CO-REGULATION OF UROKINASE RECEPTOR AND CXCR4 EXPRESSION 144
Discovery of New Inhibitors of Cdc25B Dual Specificity Phosphatases by Structure-Based Virtual Screening. 143
Upar soluble forms and hematopoietic stem cell transplantion 142
Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. 138
Urokinase-type plasminogen-activator and normal thyroid cell adhesion to the extracellular matrix 138
The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. 137
Hp(2-20) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors. 134
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 134
Recent advances in the function of the 67 kDa laminin receptor and its targeting for personalized therapy in cancer 134
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 133
Upregulation of the N-formyl peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts 132
Involvement of the 67 kDa laminin receptor in haematopoietic stem cell mobilisation and homing 131
The metastasis-associated 67kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 131
The plasminogen activator system in fibroblasts from systemic sclerosis. 130
The urokinase receptor associates to fMLF chemotaxis receptors 128
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. 125
Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence. 123
Production of urokinase-type plasminogen activator by normal and transformed rat thyroid cells in culture. 121
Role of the Urokinase Receptor (uPAR) in the Cross-Talk of Hematopoietic Stem Cells with the Bone Marrow Microenvironment 120
uPAR REGULATES PERICELLULAR PROTEOLYSIS THROUGH A MECHANISM INVOLVING INTEGRINS AND fMLF-RECEPTORS 118
In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. 117
N-formyl peptide receptors induce radical oxygen production in fibroblasts derived from systemic sclerosis by interacting with a cleaved form of urokinase receptor 115
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? 114
The metastasis-associated 67 kDa laminin receptor is involved in G-CSF-induced haematopoietic stem cell mobilisation 114
Structure and Functions of the Urokinase Receptor 111
Role of the urokinase-type plasminogen activator receptor in haematopoietic stem cell mobilisation 108
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 108
Post-transcriptional regulation of gene expression in the plasminogen activation system. 101
Scleroderma and plasminogen activation system: Expression and function of the urokinase-mediated plasminogen activation system in fibroblasts from systemic sclerosis | 101
The cleavage of the urokinase receptor regulates its multiple functions. 99
uPAR and Proteases in Mobilizationof Hematopoietic Stem Cells 99
New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms 95
Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children 92
TLR4 Response to LPS Is Reinforced by Urokinase Receptor 90
Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer 87
null 45
null 41
The urokinase receptor: A multifunctional receptor in cancer cell biology. therapeutic implications 27
Totale 17.049
Categoria #
all - tutte 38.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022486 0 0 0 3 27 12 8 18 69 71 58 220
2022/2023791 75 69 7 115 123 160 1 68 128 1 28 16
2023/2024309 31 63 19 7 14 45 9 24 2 10 6 79
2024/20251.095 32 19 13 36 48 164 188 126 140 28 123 178
2025/202610.479 1.858 3.725 2.365 230 403 196 509 100 221 414 104 354
2026/2027129 77 52 0 0 0 0 0 0 0 0 0 0
Totale 17.049